Fig. 2

Kaplan–Meier survival curves according to hematologic indexes associated with overall survival (OS) when divided into 3 groups (below/normal/above). OS outcomes according to indexes including leucocyte level, hemoglobulin concentration, neutrophil level, lymphocyte level, platelet level, serum albumin and body mass index (BMI) in pre-NACT (pre-neoadjuvant chemotherapy) (A-F) and post-NACT (post-neoadjuvant chemotherapy) (G-M). A higher pre-NACT platelet (E) and a higher post-NACT lymphocyte (J) were both associated with a preferable 3-year OS (P < 0.05)